Subclinical: ALT increased 52.2%, 67.4% AST, platelet decrease by 52.2%, 91.3% reduction PT, INR increased 91.3%, 80.4% increased total bilirubin, direct biliburin to increase 73.8%, 67.4% albumin decreased, reducing protid 100%.